secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001104659-23-047844
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio announces public offering of 4.75M shares at $9.50 per share; expects net proceeds ~$42.1M
--------------------------------------------------------------------------------

- Offered 4,750,000 shares at $9.50 per share; underwriters have 30-day option for 712,500 additional shares.
- Net proceeds expected ~$42.1 million after underwriting discounts and estimated expenses.
- Use proceeds for general corporate purposes including sales, marketing, R&D, working capital, and capex.
- Offering expected to close April 21, 2023, subject to customary conditions.
- Underwriting agreement with Jefferies, Piper Sandler, and Lake Street Capital Markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/0001104659-23-047844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/tm232660d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-047844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer